Atlas Trials

Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis

Clinical trial NCT01513161 · COMPLETED

Trial details

NCT number
NCT01513161
Sponsor
SK Chemicals Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis
Start date
2008-04-01
Primary completion
2009-10-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.